Physician profile
John L Bostanche
NPI 1821092420
$2,888.25
in general payments reported to CMS, 2019-2025
37 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,816 · 2020: $16.10 · 2021: $107 · 2022: $223 · 2023: $261 · 2024: $136 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $891.00 | 2019 | |
| Great Lakes Orthopedics | $501.81 | 2019 | |
| Celularity INC. | $146.00 | 2019 | |
| Ani Pharmaceuticals, INC. | $143.92 | 2024-2025 | Purified Cortrophin Gel |
| Next Science LLC | $108.18 | 2022-2023 | Xperience, Blastx, Surgx |
| Treace Medical Concepts, INC. | $99.19 | 2023-2025 | |
| Integra Lifesciences Corporation | $93.78 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $86.27 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $68.90 | 2022-2023 | Puraply |
| Vertex Pharmaceuticals Incorporated | $62.37 | 2025 | |
| Smith+Nephew, INC. | $61.43 | 2022-2023 | Pico, Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $61.09 | 2019 | |
| Stryker Corporation | $53.85 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $53.13 | 2019 | |
| Kerecis Limited | $38.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $34.76 | 2022-2024 | Physio-Stim |
| Melinta Therapeutics, LLC | $34.42 | 2019 | |
| Depuy Synthes Sales INC. | $34.16 | 2023 | Motoband, Na |
| Acera Surgical, INC. | $27.77 | 2021 | |
| Surgenex LLC | $23.14 | 2025 | Pellograft, Surmatrix, Surgraft |
| Medtronic, INC. | $22.51 | 2025 | Intellis Adaptivestim |
| Sebela Pharmaceuticals INC. | $21.44 | 2022 | |
| Nevro Corp. | $21.18 | 2022 | |
| Sanara Medtech INC. | $20.44 | 2021 | |
| Mimedx Group, INC. | $20.32 | 2024 | |
| Wright Medical Technology, INC. | $19.31 | 2019 | |
| Grt US Holding, INC. | $17.18 | 2021 | |
| Assertio Therapeutics, INC. | $16.73 | 2019 | |
| Avita Medical Americas, LLC | $15.33 | 2025 | Recell, Permeaderm, Cohealyx |
| Averitas Pharma INC. | $13.67 | 2023 | Qutenza |
| Pfizer INC. | $13.39 | 2019 | |
| Tactile Systems Technology INC | $12.65 | 2021 | |
| Bioventus LLC | $12.23 | 2019 | |
| Ermi LLC | $11.80 | 2021 | |
| Zimmer Biomet Holdings, INC. | $10.95 | 2019 | |
| Fidia Pharma USA INC. | $7.94 | 2019 | |
| Dynasplint Systems INC. | $7.35 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bostanche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.